Prescription cornea insert for keratoconus when vision worsens
Part of Eyes & vision clinical trials.
This trial tests whether prescription inserts placed in the cornea can improve day-to-day vision for people with keratoconus whose vision is getting worse and who have few options left. You may be able to avoid or delay corneal transplant depending on your cornea shape and thickness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 21 years or older
- Your keratoconus vision is getting worse and glasses/contacts no longer work well for daily life
- Your corneas have clear tissue in the middle (central cornea)
- Your cornea thickness at the planned incision spot is 450 microns or thicker
- A corneal transplant is currently the only remaining option to improve your functional vision
- You do not have major immune system conditions (autoimmune, immunodeficiency, or collagen vascular diseases)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests tiny plastic rings (called Intacs) that are placed in the cornea to help reshape it and improve vision. It is for people with a condition called corneal ectasia, where the cornea thins and bulges, and who are otherwise facing a cornea transplant.
This trial uses donated corneal tissue that was treated with a special light and riboflavin (collagen cross-linking) to strengthen it before transplant. The goal is to improve vision in people with severe keratoconus, a condition where the cornea bulges into a cone shape and gets very thin.
This trial tests a small metal implant placed in the cornea to treat keratoconus, a condition where the cornea thins and bulges. The goal is to see if the implant can safely improve vision and prevent the need for a corneal transplant.
This trial tests two different laser-based procedures to treat keratoconus, a condition that weakens and bulges the cornea. The goal is to see which approach better strengthens the eye and improves vision.
This study tests a procedure called Xenia corneal lenticule in people with severe keratoconus or severe post-LASIK corneal thinning who want to avoid a corneal transplant. It aims to improve vision while checking safety and how well the new procedure works over time.
This trial compares two ways to manage inflammation after corneal crosslinking for keratoconus: a tiny steroid insert placed in the tear duct versus standard steroid eye drops. It aims to see which option is easier and works just as well.
Hear when a new Keratoconus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.